U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07216911) titled 'Evaluating the Impact of Psychotherapeutic Advertising Claims on Cannabis Purchasing' on Sept. 22.

Brief Summary: In the U.S., legal cannabis is frequently advertised as an effective treatment for mental health problems such as anxiety and depression-particularly online. States that have legalized cannabis have not implemented regulations to address this type of advertising. This project aims to investigate the influence of psychotherapeutic advertising claims (PAC) and mental health warning labels (WL) on online cannabis purchasing behaviors among light-to-moderate cannabis users with symptoms of depression and/or anxiety.

The spe...